Lataa...
Novel role of phosphodiesterase inhibitors in the management of end-stage heart failure
In advanced heart failure (HF), chronic inotropic therapy with intravenous milrinone, a phosphodiesterase III inhibitor, is used as a bridge to advanced management that includes transplantation, ventricular assist device implantation, or palliation. This is especially true when repeated attempts to...
Tallennettuna:
| Julkaisussa: | World J Cardiol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Baishideng Publishing Group Inc
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4958691/ https://ncbi.nlm.nih.gov/pubmed/27468333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4330/wjc.v8.i7.401 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|